På baggrund af data for andre CYP3A4- hæmmere, forventes plasma- koncentrationen af midazolam at være betydeligt højere hvis midazolam administreres oralt.
Based on data for other CYP3A4 inhibitors, plasma concentrations of midazolam are expected to be significantly higher when midazolam is given orally.